The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | Future prospects for CAR-T cell therapy in AML
Saad Kenderian, MB, ChB, Mayo Clinic, Rochester, MN, shares some insights into future prospects for CAR-T cell therapy in acute myeloid leukemia (AML), highlighting the challenges of using CAR-T products in AML, and future outlooks. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
